Cellyan Biotechnology Co., Ltd (HKPD) Research
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
Market snapshot
- Symbol
- HKPD
- Price
- $0.40
- Day change
- -3.78%
- Market cap
- $4.3M
- P/E ratio
- -131.71x
- 52-week range
- 0.318-2.58
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
Peer companies
- Art's-Way Manufacturing Co., Inc. (ARTW)
- Addentax Group Corp. (ATXG)
- Freightos Limited Ordinary shares (CRGO)
- Jayud Global Logistics Limited (JYD)
- Lakeside Holding Limited (LSH)
- New Century Logistics (BVI) Limited (NCEW)
- PS International Group Ltd. (PSIG)
- Ten-League International Holdings Limited Ordinary Shares (TLIH)
Recent insider activity
- CHAN Kam Leung — trade (0 shares) on 2026-03-18
- Wong Lap Sun — trade (0 shares) on 2026-03-18
- Wang Zifeng — trade (0 shares) on 2026-03-18
- Liu Shu — trade (0 shares) on 2026-03-18
- Zhou Mike Yao — trade (0 shares) on 2026-03-18
Open Cellyan Biotechnology Co., Ltd (HKPD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.